Alan Barge
Impact in
- Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Platelet Disorders and Treatments
- Oncology top 5%
- Neutropenia and Cancer Infections
- HER2/EGFR in Cancer Research
Papers in
- Oncology 9
- Cancer Treatment and Pharmacology 3
- Neutropenia and Cancer Infections 3
-
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 4
- Platelet Disorders and Treatments 3
- Co-authors
- Catherine Wheeler (5 shared papers)David C. Linch (1 shared paper)A. Zander (1 shared paper)Hartmut Link (1 shared paper)A. H. Goldstone (1 shared paper)Keith M. Borkett (1 shared paper)M. Boogaerts (1 shared paper)Norbert Schmitz (1 shared paper)
- Journals
- Blood (4 papers)Clinical Cancer Research (3 papers)Investigational New Drugs (2 papers)Annals of Oncology (2 papers)Contemporary Clinical Trials (2 papers)
- Partner nations
- United KingdomGermanyUnited States
In The Last Decade
Alan Barge
20 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 82
- Hematology 582
- Oncology 669
- Genetics 146
- Cancer Research 129
- Pathology and Forensic Medicine 144
Countries citing papers authored by Alan Barge
This map shows the geographic impact of Alan Barge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Barge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Barge more than expected).
Fields of papers citing papers by Alan Barge
This network shows the impact of papers produced by Alan Barge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Barge. The network helps show where Alan Barge may publish in the future.
Co-authors
The 25 scholars most cited alongside Alan Barge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 459 | |
| 2 | 2005 | 247 | |
| 3 | 1997 | 232 | |
| 4 | 2005 | 156 | |
| 5 | 2004 | 108 | |
| 6 | 1999 | 83 | |
| 7 | 2008 | 54 | |
| 8 | 2024 | 34 | |
| 9 | 2006 | 31 | |
| 10 | 2007 | 25 | |
| 11 | 2018 | 23 | |
| 12 | 2006 | 19 | |
| 13 | 2005 | 15 | |
| 14 | 1998 | 13 | |
| 15 | Results of a randomised, double-blind placebo controlled phase III study of filgrastim in remission induction and early consolidation therapy for adults with de-novo acute myeloid leukemia | 1995 | 12 |
| 16 | 1997 | 11 | |
| 17 | [The ABO system and transplantation. Effect of pre-immunization with soluble A substance]. | 1967 | 5 |
| 18 | 1999 | 4 | |
| 19 | 2014 | 2 | |
| 20 | Pharmacodynamic assessment of ZD6474 (ZACTIMA (TM)) in the skin of patients with previously treated metastatic breast cancer. | 2005 | 1 |
About Alan Barge
Alan Barge is a scholar working on Oncology, Hematology, Molecular Biology, Cancer Research and Genetics, having authored 21 papers that have together received 1.5k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (4 papers), Angiogenesis and VEGF in Cancer (3 papers), Cancer Treatment and Pharmacology (3 papers), Neutropenia and Cancer Infections (3 papers), Platelet Disorders and Treatments (3 papers), Cancer Genomics and Diagnostics (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). The work is most often cited by research in Hematology (582 citations), Oncology (669 citations), Genetics (146 citations), Cancer Research (129 citations) and Pathology and Forensic Medicine (144 citations). Alan Barge has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Catherine Wheeler, David C. Linch, A. Zander, Hartmut Link, A. H. Goldstone, Keith M. Borkett, M. Boogaerts, Norbert Schmitz, Peter Dreger and Augustin Ferrant. Their work appears in journals such as Blood, Clinical Cancer Research, Investigational New Drugs, Annals of Oncology and Contemporary Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.